BioAdaptives, Inc.
BDPT
$0.0257
$0.00124.90%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 3.20K | 700.00 | 12.70K | 19.90K | 35.50K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 3.20K | 700.00 | 12.70K | 19.90K | 35.50K |
| Cost of Revenue | 62.20K | 81.60K | 90.00K | 94.50K | 45.50K |
| Gross Profit | -58.90K | -80.90K | -77.30K | -74.60K | -9.90K |
| SG&A Expenses | 927.60K | 702.40K | 504.80K | 242.80K | 240.10K |
| Depreciation & Amortization | 1.00K | 0.00 | 1.90K | -8.90K | 28.70K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 990.70K | 784.00K | 596.70K | 328.40K | 314.40K |
| Operating Income | -987.50K | -783.30K | -584.00K | -308.50K | -278.80K |
| Income Before Tax | -764.40K | -789.50K | -899.10K | -795.60K | -771.10K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -0.76 | -0.79 | -0.90 | -0.80 | -0.77 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -764.40K | -789.50K | -899.10K | -795.60K | -771.10K |
| EBIT | -987.50K | -783.30K | -584.00K | -308.50K | -278.80K |
| EBITDA | -986.60K | -782.90K | -582.10K | -299.50K | -232.20K |
| EPS Basic | -0.08 | -0.13 | -0.14 | -0.13 | -0.12 |
| Normalized Basic EPS | -0.05 | -0.08 | -0.09 | -0.08 | -0.06 |
| EPS Diluted | -0.08 | -0.13 | -0.14 | -0.13 | -0.12 |
| Normalized Diluted EPS | -0.05 | -0.08 | -0.09 | -0.08 | -0.06 |
| Average Basic Shares Outstanding | 34.46M | 27.92M | 26.57M | 30.89M | 29.78M |
| Average Diluted Shares Outstanding | 34.46M | 27.92M | 26.57M | 30.89M | 29.78M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |